KAILA SINCLAIR: Open Payments
NPI 1689166126 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 66 payments from 11 companies in 2025. Trend: 2023 $730 · 2024 $622 · 2025 $1,413
Food & beverage: $1,313Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 35 | $830 |
| ABBVIE INC. | 9 | $143 |
| UCB, Inc. | 4 | $88 |
| STRATA Skin Sciences, Inc. | 6 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Amgen Inc. | 2 | $55 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Organon LLC | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: TREMFYA, Bimzelx, XTRAC, SKYRIZI, Otezla, BOTOX, SPEVIGO, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
